Auro Laboratories Ltd

On 03-Dec, Auro Laboratories Ltd’s stock price edged higher by 0.24% to ₹255.90, continuing a positive trend that has seen the share gain over 5% in the past four trading sessions. This upward movement reflects the company’s sustained outperformance relative to its sector and benchmark indices, supported by robust technical indicators despite a decline in investor participation.

Auro Labs reported a net profit of 1.84 crore and total operating income of 19.40 crore for the year ending March 2025, with a profit after tax margin of 9.48% and an operating profit margin of 17.58%. Total liabilities increased to 99.10 crore, driven by long-term borrowings of 30.79 crore, while shareholder's funds grew to 42.97 crore.

As of 13-Nov, Auro Laboratories Ltd's stock price is at Rs 219.40, up 19.99% today, but year-to-date it is down 17.86%. Despite strong short-term performance, investor participation has declined, indicating mixed sentiment.

Auro Labs has experienced a significant decline in financial performance, with net sales dropping from 53.64 Cr in March 2024 to 19.40 Cr in March 2025, and profits decreasing sharply, while total liabilities have increased, indicating a growing debt burden.

Auro Laboratories' latest financial results are poor, with a 42.80% decline in net sales and profit after tax, and a significant drop in earnings per share to Rs -0.18. The company has faced ongoing challenges, reflected in its lowest operating profit in five quarters and a substantial quarterly sales decline of 62.57%.

Auro Labs will announce its results on 12 November 2025.

As of 07-Nov, Auro Laboratories Ltd's stock price is Rs 183.35, down 1.85% after a three-day decline of 7.07%. The stock is trading below all major moving averages, indicating a bearish trend, and has underperformed the Sensex significantly over the past month and year-to-date.

As of 31-Oct, Auro Laboratories Ltd's stock price is Rs 193.95, up 3.91%, but it remains below key moving averages, indicating a longer-term downward trend. The stock has underperformed against the Sensex, with significant recent declines despite today's gains.

As of 27-Oct, Auro Laboratories Ltd's stock price is Rs 204.35, down 5.42%, and has underperformed its sector significantly. The stock has declined 23.49% year-to-date, contrasting with the Sensex's 8.50% gain, indicating a bearish trend and investor concerns.

As of 06-Oct, Auro Laboratories Ltd's stock price is Rs 219.50, down 3.77%, and has underperformed its sector. The stock is in a bearish trend, trading below all major moving averages, and has seen a significant decline of 17.82% year-to-date, contrasting sharply with the overall market's positive performance.

Auro Labs experienced significant declines in net sales, operating income, and profits from Mar'24 to Mar'25, with net sales dropping from 53.64 Cr to 19.40 Cr and profit after tax falling from 7.79 Cr to 1.84 Cr, while total liabilities increased from 85.73 Cr to 99.10 Cr. The company faced a challenging year marked by reduced revenues and rising debts.

As of 24-Sep, Auro Laboratories Ltd is priced at 240.95 with no change, having outperformed its sector today. Despite a 21.60% return over the last year, the company faces challenges with declining sales and negative quarterly results, leading to cautious investor sentiment.